NASDAQ:REGN - Regeneron Pharmaceuticals SEC Filings & 10K Form

$320.26
-0.22 (-0.07 %)
(As of 06/24/2019 09:11 AM ET)
Today's Range
$312.00
Now: $320.26
$324.26
50-Day Range
$297.44
MA: $311.13
$338.69
52-Week Range
$295.27
Now: $320.26
$442.00
Volume1.49 million shs
Average Volume783,022 shs
Market Capitalization$35.00 billion
P/E Ratio16.17
Dividend YieldN/A
Beta1.13

SEC Filings

Regeneron Pharmaceuticals (NASDAQ:REGN) SEC Filings

DateFilerForm TypeView
06/19/2019
4:20 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/29/2019
3:16 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2019
7:42 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/15/2019
3:02 PM
Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/14/2019
9:42 AM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/09/2019
3:40 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/07/2019
4:00 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K/A
View Filing
05/07/2019
1:03 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/07/2019
6:50 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/07/2019
6:35 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/03/2019
3:01 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/26/2019
3:05 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/26/2019
3:02 PM
Regeneron Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/18/2019
6:04 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
04/10/2019
4:12 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/22/2019
3:03 PM
Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2019
7:19 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
11:02 AM
FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/11/2019
2:14 PM
Regeneron Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/07/2019
3:12 PM
Regeneron Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/06/2019
6:48 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/18/2019
4:01 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/11/2019
3:06 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/07/2019
6:13 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/04/2019
3:09 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
3:08 PM
COLES N ANTHONY (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
3:07 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
3:05 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/04/2019
3:04 PM
Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/20/2018
4:36 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/17/2018
3:08 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
3:02 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:49 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:21 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:19 PM
Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:18 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:12 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:08 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:06 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:05 PM
Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/14/2018
3:03 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
11/13/2018
3:31 PM
Regeneron Pharmaceuticals (Filer)
Form S-3ASR
View Filing
11/06/2018
6:56 AM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
11/06/2018
6:39 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/12/2018
6:45 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/01/2018
3:06 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/28/2018
3:35 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/25/2018
3:05 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/11/2018
3:04 PM
Landry Robert E (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/10/2018
4:01 PM
Regeneron Pharmaceuticals (Issuer)
Sanofi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/31/2018
3:02 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/23/2018
3:01 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/21/2018
3:55 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/03/2018
3:03 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/02/2018
3:11 PM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/02/2018
6:41 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/26/2018
1:28 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
View Filing
07/11/2018
3:04 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/09/2018
3:04 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/22/2018
3:03 PM
Regeneron Pharmaceuticals (Issuer)
VAGELOS P ROY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/13/2018
3:01 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/25/2018
3:03 PM
Regeneron Pharmaceuticals (Issuer)
STAHL NEIL (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
3:02 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/03/2018
3:02 PM
Regeneron Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/03/2018
6:53 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/23/2018
3:50 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/23/2018
3:47 PM
Regeneron Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/23/2018
3:44 PM
Regeneron Pharmaceuticals (Filer)
Form DEF 14A
View Filing
03/19/2018
3:47 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/14/2018
3:01 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
3:01 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2018
8:43 AM
FMR LLC (Filed by)
Regeneron Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/12/2018
4:17 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/12/2018
4:12 PM
McCourt Marion (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
View Filing
02/09/2018
9:43 AM
Regeneron Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G
View Filing
02/08/2018
3:22 PM
Regeneron Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
02/08/2018
3:06 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/08/2018
6:36 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/05/2018
3:02 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
01/18/2018
3:01 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/17/2018
3:07 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/09/2018
4:20 PM
Regeneron Pharmaceuticals (Subject)
Sanofi (Filed by)
Form SC 13D/A
View Filing
01/09/2018
2:01 PM
Regeneron Pharmaceuticals (Filer)
Form CT ORDER
View Filing
01/08/2018
5:55 AM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/03/2018
3:14 PM
BAKER CHARLES A (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:14 PM
Regeneron Pharmaceuticals (Issuer)
Zoghbi Huda Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:13 PM
BROWN MICHAEL S (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:13 PM
Regeneron Pharmaceuticals (Issuer)
Tessier-Lavigne Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:13 PM
Regeneron Pharmaceuticals (Issuer)
SING GEORGE L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:12 PM
Bassler Bonnie L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:12 PM
GOLDSTEIN JOSEPH L (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:11 PM
Regeneron Pharmaceuticals (Issuer)
RYAN ARTHUR F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/03/2018
3:10 PM
POON CHRISTINE A (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/02/2018
3:05 PM
Regeneron Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/20/2017
3:05 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2017
4:17 PM
Regeneron Pharmaceuticals (Issuer)
SCHLEIFER LEONARD S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2017
4:17 PM
Regeneron Pharmaceuticals (Issuer)
YANCOPOULOS GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2017
3:53 PM
LAROSA JOSEPH J (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2017
3:53 PM
Fenimore Christopher R. (Reporting)
Regeneron Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/13/2017
3:53 PM
Regeneron Pharmaceuticals (Issuer)
Van Plew Daniel P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
This page was last updated on 6/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel